Lipidome profiling in advanced metabolic liver disease identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism
Francis GL, Ross M, Ballard FJ, Milner SJ, Senn C, McNeil KA, Wallace JC, King R, Wells JR (1992) Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency
TRIUMPH-4: knee osteoarthritis (completed) TRIUMPH-4 is the first and, as of April 2026, the only Phase 3 trial to report results
In October 2025 the FDA approved oral semaglutide to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes at high cardiovascular risk, covering both primary and secondary prevention, based on the SOUL trial
Because compounded drugs are not approved by the FDA, this means that the FDA has not confirmed the safety, effectiveness, and quality of these products
To counter this, its important to be intentional with portion sizes and prioritize nutrient-dense foods that keep you satisfied for longer